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Abstract
Objective Evidence suggests peer support (PS) is as an effective strategy for enhancing prevention and control of chronic and 
infectious diseases, including cancer. This systematic scoping review examines the range and variety of interventions on the use 
of PS across the cancer care continuum.
Method We used a broad definition of PS to capture a wide-range of interventions and characterize the current status of the field. 
Literature searches were conducted using PubMed, SCOPUS, and CINAHL to identify relevant articles published from January 
2011 to June 2016. We screened the title and abstracts of 2087 articles, followed by full-text screening of 420 articles, resulting in 
a final sample of 242 articles of which the most recent 100 articles were reviewed (published June 2014 to May 2016). 
Results A number of the recent intervention studies focused on breast cancer (32%, breast cancer only) or multiple cancer sites 
(23%). Although the interventions spanned all phases of the cancer care continuum, only 2% targeted end-of-life care. Seventy-
six percent focused on clinical outcomes (e.g., screening, treatment adherence) and 72% on reducing health disparities. 
Interventions were primarily phone-based (44%) or delivered in a clinic setting (44%). Only a few studies (22%) described 
the impact of providing PS on peer supporters.
Electronic supplementary material The online version of this article
(https://doi.org/10.1007/s00520-018-4479-4) contains supplementary
material, which is available to authorized users.
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Conclusion PS appears to be a widely used approach to address needs across the cancer care continuum, with many opportunities
to expand its reach.
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Introduction
Cancer is a leading cause of global mortality, accounting for
over 8.7 million deaths in 2015 [1]. Over the last decade,
substantial progress has been made in regard to prevention,
diagnostic, and treatment options for the majority of cancer
types [2, 3]. However, the burden of cancer-related mortality
is still rising, particularly in lower-middle income countries
where 85% of the world’s population resides [4]. This is due
in part to changing demographics, exposure to environmental
carcinogens and cancer-causing infectious diseases, and the
adoption of lifestyle behaviors that increase cancer risk (e.g.,
physical inactivity, unsafe reproductive patterns, unhealthy
eating, as well as alcohol and tobacco use) [1, 4]. Given the
breadth of specific cancers and diversity in associated risk
factors, effective approaches for cancer control and prevention
must be both adaptable and comprehensive.
Despite advances across the cancer care continuum, chal-
lenges persist. Studies show that patients have barriers
accessing care including screenings and treatment services
[5, 6]. Patients in rural areas lacking or with small health
centers may require travel to receive quality care [7].
Initiating and sustaining a healthy lifestyle becomes a chal-
lenge for some during treatment and survivorship [8–10].
Once a person is diagnosed, there are barriers to follow-up.
In addition to financial barriers, Palmer et al. notes the need
for psychosocial care to reduce fear of recurrence to improve
follow-up among African American breast cancer survivors
[11]. Research indicates the need for communication to help
patients understand the complexities of cancer information to
assist with decision-making for screening and treatment and
during survivorship [12]. Lack of social support, depression,
and distress were also indicated in studies as relevant for
cancer-related outcomes [13–15].
Peer support (PS) is an effective disease prevention and
management strategy to enhance linkages to care and attend
to the dynamic and evolving conditions of real world environ-
ments and circumstances that influence health behavior
[16–23]. As used here, PS is defined by the functions and
principles that comprise it and not restricted to specific no-
menclature commonly used in the reviewed literature (e.g.,
“community health workers,” “lay health advisors,” and “peer
navigators” among others) [24]. By providing individuals as-
sistance for daily management, addressing complex emotional
and social issues, linking individuals to resources in clinic and
community settings (e.g., navigation of health care systems),
and providing ongoing care, peer supporters have effectively
addressed diverse health needs and served in a variety of ca-
pacities and settings [25–27]. In other words, PS is a strategy
for providing help and support to others and is often delivered
by non-professionals (i.e., peers).
Across the cancer care continuum, PS has emerged as an
important strategy to address many barriers to cancer preven-
tion [28], early detection [29, 30], treatment [22, 31], and
survivorship [22, 31]. Peer supporters often work with pa-
tients and/or health care providers to address system-level
barriers, such as fragmented care, financial constraints, other
practical challenges (e.g., transportation, employment con-
cerns, child care), and communication difficulties [25, 32].
PS programs in cancer have been shown to increase patient
satisfaction; improve psychological adjustment, such as in-
creased hope and decreased emotional distress; and increase
skills and knowledge to cope with cancer, such as decision-
making [22, 31, 33]. Despite growing evidence on the effec-
tiveness of PS programs [34], research is needed about how
PS is being applied across the cancer care continuum, how PS
is being delivered and for whom, and where opportunities
exist for extending the reach and scope of PS.
Hence, the purpose of this scoping systematic review of
recent literature is to characterize PS usage from primary pre-
vention to end-of-life care among adult populations or fami-
lies of adults affected by cancer (e.g., family caregivers). Our
specific research questions are (as reflected in peer-reviewed
literature) as follows:
1. What are the areas in which PS is used in cancer preven-
tion, early detection, and care?
2. To what extent and/or how is PS used to address dispar-
ities in cancer care?
3. Who are the peer supporters? (E.g., What relation do they
have to participants? How are they employed?)
4. What are the characteristics of PS programs?
5. What outcomes are examined by PS programs?
Methods
Scoping systematic reviews are commonly used to convey the
breadth and depth of a topic of study, summarize evidence,
and identify gaps in existing literature [35]. There are a num-
ber of differences between scoping reviews and systematic
reviews. First, while systematic reviews are often used to an-
swer a specific question according to a fixed set of a priori
factors, scoping reviews use broader approaches (i.e., incor-
porating a range of evidence) and have broader research ques-
tions [36]. Second, scoping reviews are designed to provide an
overview of existing literature and often incorporate a range of
study designs and articles without an assessment of quality
[36]. Finally, scoping reviews are typically more iterative than
systematic reviews. Search terms can be redefined and steps
may be repeated to make sure that the literature is covered in a
comprehensive way [37]. Although many scoping reviews are
systematic, in some cases, researchers do not place strict lim-
itations at the outset regarding search terms, identification of
relevant studies, or study selection [37].
In line with other reviews of this type [38, 39], our key
steps for completing this review included the following: (1)
identifying our research questions, (2) determining the search
strategy, (3) pilot testing and refining our search strategy, (4)
using eligibility criteria to select studies through title, abstract,
and full-text review, (5) extracting data from selected articles
to answer the research questions, and (6) summarizing the
contributions and gaps based on the extracted data and recent
literature. We created a written protocol to guide steps for
completing the review. All members of the scoping review
team had graduate level training, and a sub-group of four
members (NB, VC, KE, SK) comprised the leadership team
for the review.
Search strategy
A comprehensive and systematic literature search was con-
ducted inMEDLINE/PubMed, Scopus, and CINAHL to iden-
tify relevant articles published over the previous 5 years
(January 1, 2011 through June 2, 2016). The literature search
included Medical Subject Headings (MeSH), CINAHL
Headings, and related text and keyword searches, focusing
on terms to describe PS roles used in the cancer care contin-
uum. The research team and a cancer information librarian
developed the search strategy; the librarian conducted the
searches. Details of the search strategy are reported in the
supplemental materials. A total of 3789 articles were identi-
fied, of which 2087 were non-duplicates.
Inclusion and exclusion criteria
Studies considered for our review had to include the provision
of PS during one or more aspects of the cancer care continuum
(prevention through end-of-life) for adults over the age of 18.
Since our overarching goal was to characterize the application
of PS in cancer, we included articles where the qualifications
of peer supporters were, and were not, well defined. There was
no minimum requirement on the number of interactions be-
tween a peer supporter and peer recipient. We included sup-
port groups led by a professional if they clearly stated that PS
was a program objective, PS groups were led by peers, or
some hybrid of the two. We excluded studies where support
was provided solely by researchers or health care profes-
sionals with post-baccalaureate training serving in an employ-
ment capacity, such as nurses, social workers, physicians, di-
eticians, physical therapists, and mental health professionals
(e.g., programs in which Cognitive Behavior Therapy was
provided by psychologists or social workers were excluded).
We also excluded (1) articles if we could not locate a copy to
review, (2) articles in which no English version was available,
(3) dissertations, and (4) conference proceedings. Since the
goal of this review was to characterize the current field of
PS, we included all studies regardless of study design the
cancer care continuum (prevention through end-of-life) for
adults over the age of 18..
Article selection
The online software program Covidence [40] was used to
complete article screening. Pairs of research team members
independently screened all titles and abstracts for inclusion.
Titles and abstracts that lacked adequate information to deter-
mine inclusion or exclusion underwent a full-text review. A
total of 1667 articles were excluded during the initial abstract
screening phase. At the full-text review stage, each member of
the research team independently reviewed each of the 420
remaining full-text articles for inclusion or exclusion based
on the eligibility criteria. An additional 180 articles were ex-
cluded during the full-text review phase, leaving 242 articles.
During the data extraction phase, four additional articles were
excluded for eligibility reasons, leaving 238 articles that met
all eligibility criteria for inclusion in this study. Consistent
with our goal to scope the existing literature to demonstrate
the state of PS in cancer and disseminate in-depth and broad
results, the study team then selected the 100 most recent arti-
cles for data extraction and summarization. This constituted
then a broad sample with no apparent bias of the current liter-
ature on PS we sought to characterize, representing publica-
tion dates over a 2-year period, from June 2014 through May
2016. In addition, narrowing our time frame to the 100 most
recent articles facilitated expeditious review of a broad range
of literature in an in-depth manner—key goals of scoping
reviews [37]. The disposition of articles is shown in Fig. 1.
A list of all included studies is in the supplemental materials.
Categorization and synthesis
Data were collected in the REDCap database [41] using a
form that included information about the article citation, study
characteristics (e.g., length of program, location, funding, pro-
gram design), study design and setting, characteristics of study
participants, types of cancers and outcomes in selected studies,
and characteristics of PS programs. Eleven team members ex-
tracted information from the 100 articles. We assessed reliability
on 10 articles that were dual-coded by two different reviewers
(10% of the 100 identified articles) [42]. Our overall interrater
reliabilitywas 86.8%.Members of the leadership teamworked in
pairs to resolve conflicts through discussion and consensus and
to determine article eligibility, where necessary.
Data availability The authors have control of all primary data
and would allow the journal to review the data if requested.
For data not shown in Tables 1–4, please see the online sup-
plementary tables.
Results
Location and participant characteristics
As noted in Table 1, the majority of the PS programs were
conducted in the USA (80%) and in urban settings (26%).
Most often, programs included individuals from multiple racial/
ethnic backgrounds, with a smaller percentage focused only on
Black or African American populations (14%) or Latino/
Hispanic populations (19%). In addition, most programs focused
only on females (50%) or both males and females (39%), with
few focusing only onmen (7%). Few PS programs (2%) focused
specifically on older adults (age 65 or older) and none focused
only on younger adults (age 18–24).
PS program characteristics
Setting As shown in Table 2, many PS programs included
multiple settings for intervention delivery (23%), with the
Table 1 Study location and sample participant characteristics




Both international and USA 2 (2.0)
Not reported or unclear 2 (2.0)
Type of location




Multiple types of locations 4 (4.0)
Not applicable (outside of USA or unclear) 20 (20.0)
Not reported or unclear 43 (43.0)
Race/ethnicity (only among US articles)
White 2 (2.0)
Black or African American 14 (14.0)
Asian 5 (5.0)
Pacific Islander or Hawaiian Native 0 (0)
American Indian or Alaska Native 1 (1.0)
Latino/Hispanic 19 (19.0)
Other 2 (2.0)
Multiple racesa 28 (28.0)
Not applicable (outside of USA) 20 (20.0)





Not reported 4 (4.0)
Age
Focused on young adults (18–24) 0 (0)
Focused on adults, generally 74 (74.0)
Focused on older adults (65+) 2 (2.0)
Not reported or unclear 24 (24.0)
a Of articles that included multiple races (n = 28), most included three
races (n = 12, 12% of all studies) or four races (n = 10, 10% of all studies)
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Fig. 1 Prisma flow diagram
most common combination being clinic and community-
based (9% of all studies). In addition, many used only a com-
munity setting (14%) or included a community setting along-
side other settings (30%, data not shown in table). Few pro-
grams were delivered in only a faith-based location (3%) or
included a faith-based component (6%, data not shown in
table).
Modality The majority of programs were delivered using mul-
tiple types of modalities (29%). Of those that used only one
modality, the most common was in-person (60% of all stud-
ies). Few programswere delivered using only technology (i.e.,
online support groups, apps) (2%) or phone calls (8%). A
Table 2 Program characteristics
Variable Number of studies
(%)
Program setting for intervention delivery
Clinic 40 (40.0)
Community 14 (14.0)







Not reported or unclear 1 (1.0)
Not applicable (technology or phone-call based) 10 (10.0)









Diagnosis (decision-making) 4 (4.0)
Treatment 13 (13.0)
Survivorship 9 (9.0)
Palliative care 0 (0)
End-of-life carec 0 (0)
Multiple continuum focid 28 (28.0)












Not reported or unclear 5 (5.0)







Geographic location 1 (1.0)
Socioeconomic status 2 (2.0)
Other 1 (1.0)
Multipleh 31 (31.0)
Not applicable (disparity not discussed) 34 (34.0)
Peer training content/curriculum described in article
No 56 (56.0)
Yes 44 (44.0)
Navigation included in program
No 45 (45.0)
Yes 55 (55.0)
Person responsible for initial contact
Peer supporter 65 (65.0)
Recipient 2 (2.0)
Both 1 (1.0)
Not reported or unclear 32 (32.0)
Formal certification requirement for peer supporters
Table 2 (continued)







Not reported or unclear 44 (43.0)








Yes, required inclusion 4 (4.0)
Yes, invited inclusion 14 (14.0)




b The most common combination was two settings (n = 18). Of these
types of setting combinations, the most common combination was clin-
ic-based and community-based (n = 9, 9% of all studies)
c Note, one article discussed treatment, survivorship, palliative care, and
end-of-life care. Another article focused on every point of the continuum
d The most common combination was screening and diagnosis (n = 11,
11% of all studies)
e Note, five articles in total discussed lung cancer. However, one of these
articles discussed lung cancer and esophageal and two of these articles
discussed lung cancer and multiple other types of cancer
f Example: esophageal cancer
g The most common type of combination was breast and gynecological
(n = 9, 9% of all studies)
hMost studies focused on two disparities (n = 23), while seven articles of
articles focused on three disparities and one article focused on five dis-
parities. The most common type of disparity combination was race/eth-
nicity and SES (n = 17, 17% of all studies)
i Variable refers to whether theories, models, or frameworks were serious-
ly and substantively applied in the article (e.g., using constructs in pro-
gram development, design, or evaluation)
substantial proportion (33%), however, used a phone compo-
nent in addition to another modality (data not shown in table).
Cancer care continuum Twenty-eight percent (28%) of PS pro-
grams focused on multiple points along the cancer care continu-
um. The most commonly addressed was screening, of which
37% focused only on screening and more than half (58%) in-
cluded a screening component (data not shown in table). Points
on the continuum that received less attention were treatment
(13%) and survivorship (9%). None focused only on palliative
care or end-of-life care; however, two studies included palliative
care or end-of-life care along with other cancer care continuum
foci (data not shown in table).
Type of cancers Many programs (23%) focused on multiples
cancer types. Of these, the most common combination was
breast and gynecological (9% of all studies). With regard to
specific types of cancer, programs most frequently targeted
breast cancer only (32%) or colorectal cancer only (16%).
Few programs focused only on lung cancer (2%), however
5% of programs focused on lung cancer plus another cancer
type (data not shown in table). One percent (1%) of programs
focused only on skin cancer and 4% of programs focused on
skin cancer plus another cancer type (data not shown in table).
Disparities Over half of programs (66%) identified a specific
disparity to address (e.g., race/ethnicity, gender, age, geographic
location, socioeconomic status, etc.). Of these, most addressed
disparities involving race/ethnicity (31% of all studies) or mul-
tiple disparities, of which the most common combination was
race/ethnicity and socioeconomic status (17% of all studies).
Training Forty-four percent of articles described the content or
curriculum of peer supporters’ training.
Impacts on peer supporters Few programs focused on impacts
of the PS program on peer supporters (4%). Of those that did,
impacts described included a sense of connection (2% of all
programs), understanding of cancer (2% of all programs), giving
back (1% of all programs), and self-growth (1% of all programs)
(data not shown in table).
Other programmatic characteristics Over half of studies
(55%) described their intervention as a navigation program.
In addition, 9% included a formal requirement for certified
peer supporters, 26% noted that peer supporters were part of
the health care team, and 18% of programs included a family
member (data not shown in table).
Study characteristics
Length of PS contact It was difficult to differentiate the length
of the overall study and the length of contact between peer
supporters and recipients. Approximately half (47%) did not
provide enough detail to ascertain how long peer supporters
were in contact with recipients (Table 3). For the studies in
which data were available (53%), most peer supporters were
in contact with recipients for less than 1 month (20% of all
studies); the remainder of studies reported contact between 1
and 6 months (16% of all studies) or greater than 6 months
(17% of all studies).
Study design and outcomes Since the goal of this reviewwas to
characterize the current field of PS, we included all studies re-
gardless of study design. Studies were primarily descriptive or
observational (30%), randomized controlled trials (26%), or sin-
gle group pre-post (19%). Studies reported a variety of outcomes,
most frequently recipient engagement in clinical care only (43%)
or multiple types of outcomes (40%). Eight percent of studies
included mental health outcomes in addition to other outcomes
and 35% of studies included other psychosocial outcomes along-
side other outcomes (data not shown in table). However, no study
focused only on mental health outcomes and very few focused
only on other psychosocial outcomes, such as self-efficacy, social
support, attitudes, appraisal, or optimism (8%).
Program activities and support
Peer supporters used a variety of tools to engage with recipi-
ents, including counseling or motivational interviewing (18%
of programs used only counseling or motivational
interviewing, while 36% included these alongside other tools,
data not shown in table), pamphlets (14% used only pam-
phlets, while 33% included them alongside other tools, data
not shown in table), or a combination of tools (25%), of which
the most common combination was pamphlets and counseling
(9%) (see Table 4). Similarly, most programs reported offering
multiple types of support to recipients (71%), the most com-
mon combination of which was informational, emotional, and
behavioral support (18% of all studies). In addition, peer sup-
porters were most likely to interact individually with recipi-
ents (65%) or use multiple modes, such as individual and
group interactions. While many articles (48%) did not report
how peer supporters were affiliated with the PS program, 19%
did report that peer supporters were volunteers.
Discussion
The results from this review reflect an extensive and varied
breadth of literature reporting on the use of PS across the
cancer care continuum. Many PS programs addressed breast
and colorectal cancer screening and treatment, which may be
driven by incidence rates, public attention to these specific
cancer types, funding priorities, and availability of evidence-
based screening modalities. Results suggest the need to apply
PS strategies to cancer types other than breast and colorectal
cancers. In addition, few programs focused solely on men or
Table 3 Study characteristics
Variable Number of studies
(%)
Length of peer support contact
Less than 1 month 20 (20.0)
Between 1 month and less than 6 months 16 (16.0)
Greater than 6 months 17 (17.0)
Not reported or unclear 47 (47.0)
Study design





Other controlled triala 2 (2.0)
Single group pre-post 19 (19.0)
Descriptive or observational 30 (30.0)
Otherb 4 (4.0)
Not reported 4 (4.0)
Study funding
Federal 37 (37.0)
Private (state or regional foundation) 4 (4.0)
Private (national foundation) 12 (12.0)




Not reported 13 (13.0)
Study outcomes
Recipient engagement in clinical care 43 (43.0)
Behavioral risk 2 (2.0)
Quality of life 0 (0)
Mental health 0 (0)
Other psychosocial outcomesd 8 (8.0)





Not reported 3 (43.0)
a Examples: “Cluster-randomized at clinic level, randomized at individual
level” and “group-randomized trial with nested cohort design”
b Examples: “Simulation” or “multiple types of study designs”
c The most common type of funding combination was federal and private
(n = 11, 11% of all studies)
d Examples: appraisal, self-efficacy, social support, attitudes, optimism,
intentions, knowledge
e Examples: “cost”, “feasibility or process evaluation outcomes”, “sexual
function”, etc.
f The most common type of combination was recipient engagement in
clinical care and psychosocial outcomes (n = 16, 16% of all studies)
Table 4 Peer supporter activities, interactions, support, and affiliations
Variable Number of studies (%)
Tools used by peer supporters
Pamphlets/print materials 14 (14.0)
Videos 1 (1.0)
Counseling/motivational interviewing 18 (18.0)
Support groups 3 (3.0)
Othera 3 (3.0)
Multipleb 25 (25.0)
Not reported 36 (36.0)
Types of support provided by peer supporters
Informational support 22 (22.0)
Emotional support 3 (3.0)
Behavioral support 1 (1.0)
Tangible support 1 (1.0)
Shared activity 0 (0)
Medical appointment support 0 (0)
Other 0 (0)
Multiplec 71 (71.0)
Not reported 2 (2.0)







Not reported 6 (6.0)
PS affiliations with program
Volunteer 19 (19.0)
Program recipient 1 (1.0)
Regular staff 17 (17.0)




Not reported 48 (48.0)
PS affiliations with participant
Family member/partner 0 (0, 0)
Friend or buddy 0 (0, 0)
Fellow program recipient 1 (1.0)
Work (co-workers) 0 (0)
Church 3 (3.0)
No connection 57 (57.0)
Other 4 (4.0)
Multipleg 5 (5.0)
Not reported 30 (30.0)
a Examples include flip charts, interactive multimedia, and slide
presentations
bMost common type of combination of tools was pamphlets and counsel-
ing (n = 9, 9% of all studies)
cMost common type of combination of types of support provided was
informational, emotional, and behaviors (n = 18, 18% of all studies),
followed by tangible support and medical appointments (n = 15, 15% of
all studies)
d Examples include online interactions
eMost common type of combination of interactions was individual and
group (n = 9, 9% of all studies)
fMost common type of combination of affiliation with program was
regular staff and part-time (n = 2, 2% of all studies)
gMost common type of combination of affiliation with participant was
family and friend (n = 1, 1% of all studies), family and fellow program
recipient (n = 1, 1% of all studies), fellow program recipient and other
(n = 1, 20%), work and church (n = 1, 1% of all studies), church and other
(n = 1, 1% of all studies)
the provision of PS at late stages in cancer care (i.e., palliative
care and end-of-life). Many interventions in this review
sought to address racial or ethnic disparities in cancer out-
comes. Given the effectiveness of PS interventions in reaching
underserved and minority populations [43], continuing to pro-
mote PS to address racial disparities across the cancer contin-
uum is warranted. Despite the important, yet challenging,
work of peer supporters, few programs examined the positive
or negative impact of providing PS on individuals who fill this
role. Attention to the well-being of peer supporters is essential
for both program quality and sustainability.
Types of Cancer
While the volume of peer support appears to be driven by
cancers that have received public attention (e.g., breast cancer
and colorectal cancer) and where screening modalities are
available, this review highlights the need to better disseminate
peer support methods and practices to other cancer types, es-
pecially those cancers that may carry a stigma, such as lung
cancer. Indeed, we found only two papers focused on lung
cancer, which is the leading cause of cancer death [1].
Strikingly, this finding aligns with a 2008 systematic review
of peer support programs for people with cancer, in which the
authors found no examples of peer support programs for lung
cancer [22].
Gender
Men in the USA are more likely than women to engage in a
number of behaviors that increase their cancer risk [26] and
die from cancer [44]. However, few PS programs in our re-
view neither focused on men nor the cancers most common
among men. Conversely, 50% of studies focused only on
women and 32% only on breast cancer—the most common
cancer amongwomen. Researchers have argued that gender—
which refers to differences that stem from cultural and social
origins vs. biological factors—is an important factor to con-
sider when designing health programs [45]. Sensitivity to the
influence of gender on behavioral and psychosocial factors
across the cancer care continuum could increase the applica-
bility of and engagement in PS programs.
Psychosocial issues
Our review found that only 35 of the 100 PS programs
included psychosocial issues as outcomes. Among eight
articles that solely focused on psychosocial study out-
comes, none of them covered the cancer care continuum
periods of treatment, palliative care, or end-of-life care.
The psychosocial challenges associated with a cancer
diagnosis and treatment are complex and vary by char-
acteristics of an individual, their families, and
environment [46]. Psychosocial issues may include trou-
ble coping with illness, family and social isolation,
quality of life concerns, problems with treatment deci-
sions, and end-of-life issues [47]. Research suggests that
peer supporters are uniquely positioned to complement
formal support provided to patients, given the non-hier-
archical, reciprocal relationship between patients and
peer supporters [48].
Palliative care and end-of-life care
A striking feature of the review was that only two PS pro-
grams addressed palliative or end-of-life care. Indeed, to our
knowledge, there are few examples of peer support programs
designed to provide palliative or end-of-life care for cancer
patients, although some examples exist for other conditions
[49], such as end-of-life care for dialysis patients [50]. The
distress surrounding pain and symptom management and
death and dying are significant issues that impact both cancer
patients and their families [51]. Hence, the potential contribu-
tion of PS for those with advanced cancer and their families or
friends would seem to be substantial, especially given obser-
vations of the central contribution of emotional support from
PS even when it is not an emphasized part of protocols [25,
52]. Opportunities for PS in palliative and end-of-life care
could include (a) attention to end-of-life issues that otherwise
may be avoided until loss is imminent, (b) support for family
members coming to terms with loved ones’ worsening health,
and (c) PS for establishing relationships with palliative care
providers soon after diagnosis that continue throughout the
course of disease.
Addressing disparities
The majority (66%) of PS programs reviewed focused on at
least one historically marginalized population experiencing a
disproportionate burden of cancer mortality—most often dis-
parities by race or ethnicity. For these populations, the provi-
sion of cancer care can often be inaccessible, overwhelming,
unaccepting, or untrustworthy [53, 54]. Moreover, the use of
PS to address factors that influence disparities is likely based
on the idea of increasing patient agency [55] and decreasing
social distance within these populations [56]. Approaches to
increasing these populations’ agency include patient activa-
tion within the clinical environment and patient self-efficacy
to manage one’s health. PS may also help address perceived
and objective social distance between patients and their care
team by decreasing providers’ implicit bias that has been
shaped by our nation’s history of structural racism [56].
Future work should continue to examine how patients of color
are impacted by PS interventions, and further examine the use
of PS programs to address other types of disparities, including
those concerning age, gender, and geographic location.
Impact on peer supporter
Only four articles [57–60] reported how peer supporters
were impacted by their involvement in a PS program.
Methodological issues such as insufficient sample size
of peer supporters or a general lack of focus on the impact
of participation on those in the PS role could explain this
gap. A focus on the impact of PS provision is warranted
given the potential for both positive and negative impacts
[61]. Offering PS may provide psychosocial benefits for
those in the peer supporter role. Conversely, the psycho-
logical and emotional burden of guiding others who are
struggling through illness might be tremendous, potential-
ly worsening or contributing to health problems among
peer supporters [62]. For peer supporters going through
or recovering from their own health issues, the demands
of their position may worsen or create new health prob-
lems [62]. Of the four studies that did examine the impact
on peer supporters, self-growth and giving back were the
most common impacts reported [57–60]. Findings from
non-cancer-related PS programs have shown improve-
ments in confidence, self-esteem, and mental health
among peer supporters [63]. Future work should examine
the clinical, psychological, and emotional impact of PS
programs on people providing PS across the cancer con-
tinuum and identifying approaches to improve self-care.
Study limitations
Although meta-analysis typically errs on the side of exclu-
sion in order to increase precision in statistical analysis,
our scoping systematic review errs on the side of inclusion
in order to capture the breadth of recent articles. One lim-
itation of a scoping review, however, is our inability to
determine the effectiveness of PS interventions across the
cancer care continuum. Instead, this review details the im-
plementat ion and content of such intervent ions.
Additionally, although we single-coded the majority of in-
cluded papers, the high percent-agreement from our reli-
ability sample provides confidence in our overall conclu-
sions. Moreover, given that we limited our review to the
most recently published 100 studies, our findings are in-
fluenced by the speed of review and publishing (which
differs by journal) as well as publication bias, the tendency
for publication of studies with positive results. However,
many published systematic reviews include fewer than 100
papers and limiting our sample allowed us to answer our
research questions with comprehensive, in-depth findings.
Finally, we did not assess quality of studies. Scoping re-
views do not typically assess quality of studies [35, 37]
since they are not designed to weigh evidence or assess
quality of evidence [36].
Clinical implications
Individuals and their families face numerous challenges at
each phase of the cancer care continuum. In addition to social
workers and mental health professionals, peer supporters may
be an alternative resource for cancer patients and their families
who experience social or mental health distress. More broadly,
they may promote engagement in all phases of the continuum,
help patients understand and adhere to treatment and manage-
ment plans, and also assist families and facilitate the support
they provide. In the literature on PS in cancer care, it appears
that peer supporters are underutilized in a number of important
areas, including interventions targeting lung cancer, involving
men, and focusing on palliative care and end-of-life issues.
Future research should examine expanding the provision of
PS across the cancer continuum, particularly as it relates to the
gaps identified in this review, and assess and address the im-
pact of providing PS.
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